Palatin Technologies, Inc.   AMEX (PTN)

0.56    $0.04   8.40%
At close   Friday, Nov 26 04:00 PM

Palatin Technologies, Inc. Chart

PTN Stock Price Today

Palatin Technologies, Inc. (PTN) stock rallied over 8.40% intraday to trade at $0.56 a share on AMEX. The stock opened with a loss of -7.84% at $0.47 and touched an intraday high of $0.5576, rising 9.33% against the last close of $0.51. The stock went to a low of $0.4600 during the session.

Stock Snapshot

0.51
Prev. Close
0.47
Open
133.67M
Market Cap
238.23M
Number of Shares
0.4600
day Low
0.5576
Day High
0.56
-
P/E ratio
2.15%
Free Float in %
-0.16
EPS (TTM)
0.18
Book Value per Share
0.22
Cash Flow per Share
41.63M
Volume

Palatin Technologies, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-11-24$0.53$0.51$0.60$0.42121,969,800
2021-11-23$0.35$0.34$0.36$0.331,591,800
2021-11-22$0.38$0.35$0.38$0.351,500,500
2021-11-19$0.37$0.36$0.38$0.361,347,100
2021-11-18$0.38$0.37$0.39$0.371,585,200
2021-11-17$0.40$0.38$0.40$0.371,697,400
2021-11-16$0.40$0.39$0.40$0.381,765,800
2021-11-15$0.41$0.40$0.41$0.391,388,100
2021-11-12$0.40$0.40$0.41$0.401,150,900
2021-11-11$0.41$0.40$0.41$0.40754,900
2021-11-10$0.41$0.41$0.42$0.40813,700

Contact Details

Cedar Brook Corporate Center
4B Cedar Brook Drive
Cranbury, NJ 08512
United States
http://www.palatin.com
609 495 2200

Company Information

Employees20
Beta0.99
Sales or Revenue300000.00
5Y Sales Change-%
Fiscal Year Ends2020-06-29
SectorHealthcare
IndustryBiotechnology

About Company

Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor (MCr) 1 agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis and COVID-19. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, a dual NPR-A and NPR-C agonist to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was founded in 1986 and is based in Cranbury, New Jersey.

Frequently Asked Questions

What is the current Palatin Technologies, Inc. (PTN) stock price?

Palatin Technologies, Inc. (AMEX: PTN) stock price is $0.56 as of the last check on Friday, Nov 26. During the trading session, PTN stock reached the peak price of $0.5576 while $0.4600 was the lowest point it dropped to.

PTN's industry and sector of operation?

The AMEX listed PTN is part of Biotechnology industry that operates in the broader Healthcare sector. Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

Who are the executives of PTN?

Dr. John K. A. Prendergast
Co-Founder & Independent Non-Exec. Chairman

Dr. Carl Spana
Co-Founder, Pres, CEO & Director

Mr. Stephen T. Wills CPA, CPA, MST
CFO, COO, Exec. VP, Treasurer & Sec.

Burns McClellan
VP of Investor Relations


What is the PTN stock price today?

PTN stock traded closed the last session at $0.56, which is $0.04 or 8.40% higher than its previous close of $0.51. PTN's current trading price is -57.11% lower than its 52-week high of $1.30 where as its distance from 52-week low of $0.33 is 68.97%.

How many employees does PTN have?

Number of PTN employees currently stands at 20. PTN operates from Cedar Brook Corporate Center 4B Cedar Brook Drive Cranbury, NJ 08512 United States.

Link for PTN official website?


How do I contact PTN?

PTN could be contacted at Cedar Brook Corporate Center 4B Cedar Brook Drive Cranbury, NJ 08512 United States, or at phone # 609 495 2200 and can also be accessed through its website: http://www.palatin.com

How many shares of PTN are traded daily?

PTN stock volume for the day was 41.63M shares while in the previous session number of PTN shares traded was 121.97M. The average number of PTN shares traded daily for last 3 months was 2.83M.

How much did PTN change today?

The percentage change in PTN stock occurred in the recent session was 8.40% while the dollar amount for the price change in PTN stock was $0.04.

What price range PTN stock been trading in?

In the recent session, the day high for PTN stock was $0.5576 while the low for PTN stock touched on the day was $0.4600.

What is the market cap of PTN currently?

The market value of PTN currently stands at $133.67M with its latest stock price at $0.56 and 238.23M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam